Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine

被引:43
作者
de Kleijn, E
van Eijndhoven, L
Vermont, C
Kuipers, B
van Dijken, H
Rümke, H
de Groot, R
van Alphen, L
van den Dobbelsteen, G
机构
[1] Natl Inst Publ Hlth & Environm, RIVM, Lab Vaccine Res, NL-3720 BA Bilthoven, Netherlands
[2] Univ Rotterdam, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands
关键词
isotype distribution; meningococcal B vaccine; children;
D O I
10.1016/S0264-410X(01)00371-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A clinical phase II trial with the RIVM hexavalent OMV vaccine containing six different PorAs was carried out in toddlers (2-3 years) and schoolchildren (7-8 years) in The Netherlands. Children were vaccinated three times (0, 2, 8 months). Sera after two and three vaccinations were analysed for serum bactericidal activity (SBA) and isotype distribution in whole cell enzyme linked immunosorbent assay (ELISA). The SBA after vaccination against the six PorAs was significantly different. We investigated whether the age specific and PorA specific differences in SBA titers correlated with differences in PorA specific IgG isotype distribution. The SBA titers were higher in toddlers compared with schoolchildren. After vaccination, IgG I antibodies dominated the response followed by IgG3 antibodies. IgG2 levels were low. whereas IgG4 was not detected. Irrespective of PorA, IgG total and isotype specific titers after two and three vaccinations were significantly higher in toddlers than in schoolchildren. A weak correlation was found between IgG total or IgG I and SBA. Although the immunogenicity of the six PorAs is very different, the isotype distribution was similar for all six tested PorAs. We conclude that the RIVM hexavalent PorA vesicle vaccine induces bactericidal antibodies mainly of the IgG1 and IgG3 isotypes that are considered to be most important for protection against disease. The isotype distribution of the response is not age-dependent. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:352 / 358
页数:7
相关论文
共 29 条
  • [21] HUMAN-ANTIBODY RESPONSES TO MENINGOCOCCAL OUTER-MEMBRANE ANTIGENS AFTER 3 DOSES OF THE NORWEGIAN GROUP-B MENINGOCOCCAL VACCINE
    ROSENQVIST, E
    HOIBY, EA
    WEDEGE, E
    BRYN, K
    KOLBERG, J
    KLEM, A
    RONNILD, E
    BJUNE, G
    NOKLEBY, H
    [J]. INFECTION AND IMMUNITY, 1995, 63 (12) : 4642 - 4652
  • [22] MEASUREMENTS OF SERUM IGA AND IGG ACTIVITIES TO DIETARY ANTIGENS - A PROSPECTIVE-STUDY OF THE DIAGNOSTIC USEFULNESS IN ADULT CELIAC-DISEASE
    SCOTT, H
    FAUSA, O
    EK, J
    VALNES, K
    BLYSTAD, L
    BRANDTZAEG, P
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1990, 25 (03) : 287 - 292
  • [23] IGG SUBCLASS ANTIBODIES TO SEROGROUP-B MENINGOCOCCAL OUTER-MEMBRANE ANTIGENS FOLLOWING INFECTION AND VACCINATION
    SJURSEN, H
    WEDEGE, E
    ROSENQVIST, E
    NAESS, A
    HALSTENSEN, A
    MATRE, R
    SOLBERG, CO
    [J]. APMIS, 1990, 98 (12) : 1061 - 1069
  • [24] Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines - A randomized controlled trial in Chile
    Tappero, JW
    Lagos, R
    Ballesteros, AM
    Plikaytis, B
    Williams, D
    Dykes, J
    Gheesling, LL
    Carlone, GM
    Hoiby, EA
    Holst, J
    Nokleby, H
    Rosenqvist, E
    Sierra, G
    Campa, C
    Sotolongo, F
    Vega, J
    Garcia, J
    Herrera, P
    Poolman, JT
    Perkins, BA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (16): : 1520 - 1527
  • [25] Specific IgG(4) responses during chronic and transient antigen exposure in aspergillosis
    Tomee, JFC
    Dubois, AEJ
    Koeter, GH
    Beaumont, F
    vanderWerf, TS
    Kauffman, HF
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (06) : 1952 - 1957
  • [26] ISOLATION OF NEISSERIA-MENINGITIDIS MUTANTS DEFICIENT IN CLASS-1 (PORA) AND CLASS-3 (PORB) OUTER-MEMBRANE PROTEINS
    TOMMASSEN, J
    VERMEIJ, P
    STRUYVE, M
    BENZ, R
    POOLMAN, JT
    [J]. INFECTION AND IMMUNITY, 1990, 58 (05) : 1355 - 1359
  • [27] Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides
    Usinger, WR
    Lucas, AH
    [J]. INFECTION AND IMMUNITY, 1999, 67 (05) : 2366 - 2370
  • [28] CONSTRUCTION OF NEISSERIA-MENINGITIDIS STRAINS CARRYING MULTIPLE CHROMOSOMAL COPIES OF THE POR-A GENE FOR USE IN THE PRODUCTION OF A MULTIVALENT OUTER-MEMBRANE VESICLE VACCINE
    VANDERLEY, P
    VANDERBIEZEN, J
    POOLMAN, JT
    [J]. VACCINE, 1995, 13 (04) : 401 - 407
  • [29] Specificity of human bactericidal antibodies against PorA p1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine
    VanDerVoort, ER
    VanDerLey, P
    VanDerBiezen, J
    George, S
    Tunnela, O
    VanDijken, H
    Kuipers, B
    Poolman, J
    [J]. INFECTION AND IMMUNITY, 1996, 64 (07) : 2745 - 2751